| |
Centre for Policy on Ageing | |
 | |
|
| Drugs for dementia, treatment effects on quality of life | | Author(s) | Peter J Connelly, Neil Prentice, Emma Law |
| Journal title | Generations Review, vol 11, no 3, September 2001 |
| Pages | pp 17-18 |
| Keywords | Dementia ; Drugs ; Quality of life ; Evaluation. |
| Annotation | Three drugs - Donepezil, Rivastigmine, and Galantamine - have been licensed in the UK for treatment of early Alzheimer's disease (AD). The authors summarise their research on cholinesterase inhibitors, with reference to incorporating some aspects of quality of life assessment in dementia into an identification and treatment study of AD. (RH). |
| Accession Number | CPA-011019214 A |
| Classmark | EA: LLD: F:59: 4C |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|